OmniAb Share Price

OmniAb Share Price

NASDAQ: OABIW | Micro Cap | Healthcare
$0.16
-$0.20 (-55.78%) Last updated on 15 Oct, 2026 | 20:17 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

OmniAb Stock Performance

Open
N/A
Prev. Close
$0.37
Circuit Range
N/A
Day Range
N/A
Year Range
$0.07 - $0.37
Volume
N/A
Average Traded
N/A

OmniAb Share Price Chart

$0.00$0.00
L
Show Current Price
H

OmniAb Stock Fundamentals & Key Indicators

Market Cap
$18.47M
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$18.67B
Return On Equity (TTM)
-17.45%
Profit Margin
-346.97%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-10.93%

OmniAb Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$8.38$14.43$13.42$3.99
Net Profit-$14.18-$7.71-$5.86-$15.73
Net Profit Margin-169.21%-53.43%-43.67%-394.24%
Income ChangeN/A45.63%23.99%-168.43%

OmniAb Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$59.08$34.16$26.39$18.67
Net Profit-$22.33-$50.62-$62.03-$64.78
Net Profit Margin-37.80%-148.19%-235.05%-346.97%
Income ChangeN/A-126.69%-22.54%-4.43%

OmniAb Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets235.57257.42280.32296.26
Current Assets65.3468.1494.9124.95
Total Assets300.91325.56375.23421.21
Non Current Liabilities17.6322.8537.5253.82
Current Liabilities16.2515.0923.1226.02
Total Liabilities33.8937.9460.6479.84
Shareholders' Equity267.03287.62314.59341.37

OmniAb Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-36.46-39.662.35-3.0
Investing6.4737.88-18.38-73.31
Financing27.9113.02-0.89110.15

About OmniAb

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

OmniAb Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.16
$0.16
-55.86%
Sep 2026
$0.37
$0.37
+58.19%
Aug 2026
$0.23
$0.23
+256.92%
May 2026
$0.07
$0.07
-63.69%
Aug 2025
$0.18
$0.18
-36.07%
Jul 2025
$0.22
$0.28
+61.85%
Jun 2025
$0.16
$0.17
-13.50%
May 2025
$0.35
$0.20
-42.86%
Apr 2025
$0.37
$0.35
-6.17%
Mar 2025
$0.40
$0.37
-27.01%
Feb 2025
$0.40
$0.51
+29.37%
Jan 2025
$0.34
$0.40
+16.18%

OmniAb Share Price FAQs